MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Canadian Journal of Health Technologies
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

660 results · 1 filter active ·
Results by year
20212025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
660 works in the cohort · of 4,299,418page 10 of 14

Labels cover 1 of 660 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 660 of 660 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

aboutno affunlabeled
Osimertinib (Tagrisso)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Dupilumab (Dupixent)
CDA-AMC
2025· article· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Amivantamab (Rybrevant)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Pharmacology, Toxicology and Pharmaceutics
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Zanubrutinib (Brukinsa)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Tofersen (Qalsody)
CDA-AMC
2025· article· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · insufficient_payloadconsensus · none
0
citations
aboutno affunlabeled
Tafasitamab (Minjuvi)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Metreleptin (Myalepta)
CDA-AMC
2024· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Ravulizumab (Ultomiris)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Mavacamten (Camzyos)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Naloxegol
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Ferric Carboxymaltose (Ferinject)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Pemigatinib (Pemazyre)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Selpercatinib (Retevmo)
CADTH
2022· article· en· Canadian Journal of Health Technologies· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Fostemsavir (Rukobia)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Ruxolitinib (Jakavi)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Cariprazine (Vraylar)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Polatuzumab Vedotin (Polivy)
CADTH
2024· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Equity in Health Technology Assessment
Farah Husein
2023· article· en· Canadian Journal of Health Technologies· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Trofinetide (Daybue)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Arts and Humanities
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Virtual Mental Health Counselling
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Psychology
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Evolocumab (Repatha)
CDA-AMC
2024· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Tarlatamab (Imdelltra)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Dupilumab (Dupixent)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Budesonide (Jorveza)
Reimbursement Reviews
2021· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Dostarlimab (Jemperli)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Arts and Humanities
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Alpelisib (Piqray)
Reimbursement Team
2022· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Rozanolixizumab (Rystiggo)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
fundaboutno affunlabeled
Living With Type 2 Diabetes
Jamie Anne Bentz, Rebecca Hancock, Zal Press, Francesca Brundisini, Sarah Berglas
2023· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Abemaciclib (Verzenio)
CDA-AMC
2024· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Flexible Dentures for Edentulism
CDA-AMC
2025· article· Canadian Journal of Health Technologies· Dentistry
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Estradiol and Progesterone (Bijuva)
Reimbursement Team
2022· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Difelikefalin (Korsuva)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Pembrolizumab (Keytruda)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Sotatercept (Winrevair)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Dupilumab (Dupixent)
CDA-AMC
2025· article· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Blinatumomab (Blincyto)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Pembrolizumab (Keytruda)
CDA-AMC
2025· article· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations

How this was built: Screen · Findings · About